T2 Biosystems, Inc. (TTOO) Comparison with companies in other sectors?

T2 Biosystems, Inc. has a share price of 28.05M. You can analyze T2 Biosystems, Inc. (TTOO) competitors across different market sectors through stock heatmaps.

What are TTOO's NET and operating margins?

T2 Biosystems, Inc. (TTOO) operating margin is around -5.43, and net profit margin is approximately -5.60 as of the latest reports.

In what way does TTOO's earnings per share (EPS) trend reflect its financial momentum?

T2 Biosystems, Inc. (TTOO) EPS is -0.03 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for T2 Biosystems, Inc. is -1.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for T2 Biosystems, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for T2 Biosystems, Inc. like P/E which is -0.01, P/B which is -0.05, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

T2 Biosystems, Inc.

TTOO•NASDAQ

Healthcare

Medical - Diagnostics & Research

$0.03

$0.01(100.00%)

Fundamental Analysis of T2 Biosystems, Inc. (TTOO)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.03

P/E Ratio

-1.00

ROE

2.06%

Net Margin

-5.60%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$841.36K

Shares OutstandingTotal number of shares issued

$28.05M

Book Value/ShareNet worth per share

$-0.65

Revenue/ShareAnnual revenue per share

$0.43

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.03

Net MarginNet income as percentage of revenue

-559.52%

Operating MarginOperating income as percentage of revenue

-542.59%

ROEReturn on shareholders' equity

205.97%

ROAReturn on total assets

-237.55%

ROCEReturn on capital employed

655.67%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-2.05

Cash/ShareCash and equivalents per share

$0.12

FCF YieldFree cash flow as percentage of market cap

-4352.23%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for TTOOFinancial Ratios Analysis details for TTOO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for TTOOSector Benchmarking details for TTOO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for T2 Biosystems, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of T2 Biosystems, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account T2 Biosystems, Inc.'s unique business strengths and challenges.

Key Financial Metrics for T2 Biosystems, Inc.

For T2 Biosystems, Inc., essential financial indicators include EPS -0.03, PE -1.00, and ROE 2.06. These key ratios reveal insights into T2 Biosystems, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare T2 Biosystems, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of T2 Biosystems, Inc.

Metrics like Net Margin -559.52% and ROA -237.55% shed light on how well T2 Biosystems, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether T2 Biosystems, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of T2 Biosystems, Inc.

Using ratios such as P/B Ratio -0.05 and PEG Ratio -0.00, investors can assess whether T2 Biosystems, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with T2 Biosystems, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for T2 Biosystems, Inc.

Financial health indicators, such as Debt/Equity Ratio -1.62 and Cash Flow $-2.05, provide a snapshot of T2 Biosystems, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like T2 Biosystems, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for T2 Biosystems, Inc.

Investing in T2 Biosystems, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at T2 Biosystems, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;